Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
BJDX Bluejay Diagnostics
0.429-0.021-4.67%
Close
01/31 16:00 ET
High
0.450
Open
0.430
Turnover
16.40K
Low
0.420
Pre Close
0.450
Volume
37.16K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersDermata Therapeutics (NASDAQ:DRMA) stock increased by 149.3% to $0.5 during Monday's pre-market session. The company's market cap stands at $6.0 million. Allarity Therapeutics (NASDAQ:ALLR) sha
Head-To-Head Survey: ResMed (NYSE:RMD) and Bluejay Diagnostics (NASDAQ:BJDX)
ResMed (NYSE:RMD – Get Rating) and Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength
Bluejay Diagnostics (NASDAQ:BJDX) Trading 15.7% Higher
Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) shares traded up 15.7% on Thursday . The stock traded as high as $0.48 and last traded at $0.45. 9,936 shares changed hands during mid-day trading
Stocks That Hit 52-Week Lows On Friday
 On Friday, 127 companies set new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Lucid Gr (NASDAQ:LCID) was the largest company by market cap to set a new 52-week low.G Medical Innovati
12 Health Care Stocks Moving In Friday's Intraday Session
GainersAmbrx Biopharma (NYSE:AMAM) stock increased by 583.1% to $2.8 during Friday's regular session. The current volume of 68.6 million shares is 70926.8% of Ambrx Biopharma's average full-day volume
Short Interest in Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Declines By 23.8%
Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) was the target of a large decline in short interest in November. As of November 15th, there was short interest totalling 118,100 shares, a declin
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Short Interest Down 23.8% in November
Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) saw a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 118,100 shares, a
Bluejay Diagnostics (NASDAQ:BJDX) Versus Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Financial Survey
Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) and Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Rating) are both medical companies, but which is the superior business? We will contrast the two bu
Comparing Bluejay Diagnostics (NASDAQ:BJDX) and Fresenius SE & Co. KGaA (OTCMKTS:FSNUY)
Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) and Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Rating) are both medical companies, but which is the superior business? We will contrast the two co
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Large Drop in Short Interest
Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) was the recipient of a significant decrease in short interest during the month of October. As of October 31st, there was short interest totalling
Company Overview
More
Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.
CEO： Mr. Neil Dey
Market： NASDAQ
Listing Date： 11/10/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet